We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bath & Body Works (BBWI - Free Report) is a Zacks Rank #5 (Strong Sell) that operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products.
The stock continues to probe the 2022 lows after a recent earnings report that has analysts taking down estimates. With the stock off 45% for the year and 55% from all-time highs, it might be too early to start buying.
About the Company
Bath & Body Works is headquartered in Columbus, Ohio. The company was founded in 1963 and employs over 8,000 people.
The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites. The company operates over 1,700 retail stores in the U.S. and Canada, as well as over 300 international partner-operated stores.
BBWI is valued at $8.5 billion and has a Forward PE of 9. The company holds a Zacks Style Score of “A” in Value, but “C” in Growth. The stock pays out a dividend with 2.1% yield.
Q1 Earnings
The company reported EPS in mid-May, seeing a 25% beat on the bottom line. Revenues also cam in above expectations at $1.45B vs the $1.43B expected.
However, fiscal year 2022 guidance was cut from $4.56 to a range of $3.80-4.15. Q2 was also reduced, with the company now seeing $0.60-65 v the $0.65 expected. The FY22 cut shows a big range, which tells investors there is a lot of uncertainty down the road.
Management commented that the business is very strong and they saw positive store transaction trends and engagement. However, they reduced their outlook due to investment into IT, the customer loyalty program and increases in inflationary pressures.
The guidance forced analyst to cut estimates across the board.
For the current quarter, estimates have dropped from $0.68 to $0.63, or 7%. For the current year, estimates fell from $4.62 to $4.01, or 13%.
In addition to estimates going lower, analysts are dropping price targets as well. Since the earnings report we have seen the following firms drop their price targets:
JPM Chase: $67 to $63
Credit Suisse: $64 to $49
BMO: $83 to $65
Goldman Sachs: $85 to $61
UBS: $102 to $70
Technical Take
BBWI broke the 200-day moving average the first week of 2022 and hasn’t looked back. The stock is now down about 45% on the year as it trades below all the big moving averages.
The stock is barley off the lows seen in May and if that area was taken out, the stock could fall into the $20s.
Investors looking at the stock should eyeball the $23-27 area, which was the trading range before the pandemic.
In Summary
While the company did perform last quarter, Bed & Body Works has some issues over the short term. Investors should be patient while the company sorts through those issues, especially the inflationary headwinds.
For now, a better retail option might be Ulta Beauty (ULTA). The stock is a Zacks Rank #1 (Strong Buy) and the company is coming off a 42% EPS beat last month.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bear of the Day: Bath & Body Works (BBWI)
Bath & Body Works (BBWI - Free Report) is a Zacks Rank #5 (Strong Sell) that operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products.
The stock continues to probe the 2022 lows after a recent earnings report that has analysts taking down estimates. With the stock off 45% for the year and 55% from all-time highs, it might be too early to start buying.
About the Company
Bath & Body Works is headquartered in Columbus, Ohio. The company was founded in 1963 and employs over 8,000 people.
The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites. The company operates over 1,700 retail stores in the U.S. and Canada, as well as over 300 international partner-operated stores.
BBWI is valued at $8.5 billion and has a Forward PE of 9. The company holds a Zacks Style Score of “A” in Value, but “C” in Growth. The stock pays out a dividend with 2.1% yield.
Q1 Earnings
The company reported EPS in mid-May, seeing a 25% beat on the bottom line. Revenues also cam in above expectations at $1.45B vs the $1.43B expected.
However, fiscal year 2022 guidance was cut from $4.56 to a range of $3.80-4.15. Q2 was also reduced, with the company now seeing $0.60-65 v the $0.65 expected. The FY22 cut shows a big range, which tells investors there is a lot of uncertainty down the road.
Management commented that the business is very strong and they saw positive store transaction trends and engagement. However, they reduced their outlook due to investment into IT, the customer loyalty program and increases in inflationary pressures.
Bath & Body Works, Inc. Price and Consensus
Bath & Body Works, Inc. price-consensus-chart | Bath & Body Works, Inc. Quote
Estimates
The guidance forced analyst to cut estimates across the board.
For the current quarter, estimates have dropped from $0.68 to $0.63, or 7%. For the current year, estimates fell from $4.62 to $4.01, or 13%.
In addition to estimates going lower, analysts are dropping price targets as well. Since the earnings report we have seen the following firms drop their price targets:
JPM Chase: $67 to $63
Credit Suisse: $64 to $49
BMO: $83 to $65
Goldman Sachs: $85 to $61
UBS: $102 to $70
Technical Take
BBWI broke the 200-day moving average the first week of 2022 and hasn’t looked back. The stock is now down about 45% on the year as it trades below all the big moving averages.
The stock is barley off the lows seen in May and if that area was taken out, the stock could fall into the $20s.
Investors looking at the stock should eyeball the $23-27 area, which was the trading range before the pandemic.
In Summary
While the company did perform last quarter, Bed & Body Works has some issues over the short term. Investors should be patient while the company sorts through those issues, especially the inflationary headwinds.
For now, a better retail option might be Ulta Beauty (ULTA). The stock is a Zacks Rank #1 (Strong Buy) and the company is coming off a 42% EPS beat last month.